Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.78 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.78 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.78 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.78 |
| ▸ | XDH | P47989 | 6/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.78 |
| ▸ | FTO | Q9C0B1 | 6/20 | 0.78 |
| ▸ | MAPT | P10636 | 6/20 | 0.78 |
| ▸ | APP | P05067 | 6/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.78 |
| ▸ | IPMK | Q8NFU5 | 5/20 | 0.78 |
| ▸ | IP6K2 | Q9UHH9 | 5/20 | 0.78 |
| ▸ | RECQL | P46063 | 5/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.78 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12378872 | 0.92 | MEN1 (0.73) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| SCHEMBL9288825 | 0.89 | MEN1 (0.78) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL27746111 | 0.88 | MEN1 (0.94) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL29353785 | 0.87 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL31507620 | 0.87 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL17629824 | 0.87 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL29351036 | 0.87 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL29723041 | 0.87 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL19723 | 0.87 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL118425 | 0.87 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11872236-B2 | Pharmacological agents for treating ocular diseases | CALASIA PHARMACEUTICALS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| US-20230255920-A1 | METHOD FOR TREATING METASTATIC PROSTATE CANCER | THE WILLIAM M YARBROUGH FOUNDATION | 2023-08-17 | — | — | US | disclosed |
| US-20230200388-A1 | COMPOUNDS AND METHODS FOR STIMULATING PLANTS | Sound Agriculture Company (US) | 2023-06-29 | — | — | US | disclosed |
| EP-2948437-B1 | APPROACH FOR SYNTHESIS OF CATECHINS | EPIRIUM BIO INC (US) | 2021-11-03 | — | — | EP | disclosed |
| US-9458483-B2 | Compositions comprising a polypeptide having cellulolytic enhancing activity and a bicyclic compound and uses thereof | NOVOZYMES, INC. (US) | 2016-10-04 | — | — | US | disclosed |
| US-20150307908-A1 | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Bicyclic Compound And Uses Thereof | UNITED STATES DEPARTMENT OF ENERGY | 2015-10-29 | — | — | US | disclosed |
| US-9057086-B2 | Compositions comprising a polypeptide having cellulolytic enhancing activity and a bicycle compound and uses thereof | NOVOZYMES, INC. (US) | 2015-06-16 | — | — | US | disclosed |
| US-8865779-B2 | Compounds, compositions, and methods for reducing or eliminating bitter taste | CHROMOCELL CORPORATION (US) | 2014-10-21 | — | — | US | disclosed |
| US-20130217077-A1 | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Bicyclic Compound And Uses Thereof | NOVOZYMES, INC. (US) | 2013-08-22 | — | — | US | disclosed |
| US-20110190514-A1 | PYRONE ANALOG COMPOSITIONS AND METHODS | LIMERICK BIOPHARMA, INC. (US) | 2011-08-04 | — | — | US | disclosed |
| EP-2060251-B1 | Method for manufacturing active agent concentrates | COGNIS IP MAN GMBH (DE) | 2011-03-23 | — | — | EP | disclosed |
| US-20080279794-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | BASCHONG WERNER | 2008-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11872236-B2 | Pharmacological agents for treating ocular diseases | CRYAA, CRYAB, TTR | MEN1 3695/4885KMT2A 4785/4885CYP1A2 3739/4885 |
| US-20230200388-A1 | COMPOUNDS AND METHODS FOR STIMULATING PLANTS | SNRK, GRK1, PPIP5K2 | MEN1 3498/4885KMT2A 3582/4885CYP1A2 4273/4885 |
| US-20110190514-A1 | PYRONE ANALOG COMPOSITIONS AND METHODS | CYP11B2, CYP11B1, GLS2 | MEN1 535/4885KMT2A 4673/4885CYP1A2 817/4885 |
| US-20080279794-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | MEN1 659/4885KMT2A 2258/4885CYP1A2 77/4885 |
| US-20230255920-A1 | METHOD FOR TREATING METASTATIC PROSTATE CANCER | BPHL, KLK3, ACP3 | MEN1 968/4885KMT2A 378/4885CYP1A2 3719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.